Latest Biotech News

Neurovalens received FDA de novo approval for Modius Spero, a wearable neuromodulation device intended to treat PTSD in U.S. veterans, with access arranged through the Department of Veterans...

Agenus scrapped its phase 3 colorectal study after only three months, shutting down the Battman trial of botensilimab plus balstilimab in unresectable MSS metastatic colorectal cancer. The company...

MindRank raised $52 million in a Series B to advance MDR-001, its Phase III oral GLP-1 receptor agonist candidate in China. The company plans to scale its Molecule Arts Platform (MAP) and fund...

China Medical System Holdings renewed and expanded its collaboration with Insilico Medicine in a 1.2 billion yuan ($177 million) pact aimed at a mass-market central nervous system indication. The...

Insilico Medicine projected record first-half revenue and a return to profitability outlook, driven by its partnership revenue and pipeline progress, as its lead program advanced late-stage...

CMS is rolling out a GLP-1 “Bridge” program under Medicare to expand access to obesity drugs, but the design has raised immediate questions about cost, supply, and implementation. The pilot seeks...

Biotech funding in the first half rebounded in aggregate, reaching the highest total since the start of 2022, but venture investors are leaving smaller startups behind, according to industry...

Oxford Nanopore Technologies’ preliminary first-half 2026 revenue came in below management expectations, with weakness attributed to declines in China and the Middle East plus customer timing...

Researchers unveiled DeepDETAILS, a deep-learning framework designed to recover cell-type-specific gene regulation signals from bulk sequencing data. The approach targets a key limitation of bulk...

Harvard Medical School researchers published a virome-wide ubiquitin ligase discovery effort that maps diverse viral immune-evasion strategies by scaling up functional protein screens. Using...

Researchers reported in the British Journal of Cancer that blocking siglec-binding sialoglycans can interfere with prostate cancer’s ability to establish bone metastases. The study focuses on a...

Insilico Medicine’s existing partner China Medical System Holdings returned with a new collaboration to develop a “mass-market” central nervous system indication. The parties signed a 1.2 billion...

Insilico Medicine told investors it expects to be profitable in the first half of 2026, citing revenue momentum tied to collaborations and pipeline progress that includes an AI-developed lead...

AstraZeneca secured rights to a Sino Biopharmaceutical COPD molecule featuring a dual mechanism of action, according to the latest licensing report. The approach mirrors the strategy behind an...

A new JAMA case report described how amyloid clearance after amyloid-targeting therapy in Alzheimer’s disease correlates with reductions in subsequent neuropathologic changes. The analysis focuses...

Researchers identified plasma pTau217 and pTau231 as biomarkers that can forecast dementia progression in Parkinson’s disease. In a prospective longitudinal study, the plasma phosphorylated tau...

A global alliance, C-BRAIN (Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration), released three open-source AI tools designed to accelerate treatment discovery for...

Scientists published in Nature Communications a bioinspired “microcapsule reactor” system using engineered probiotics designed to modulate gut inflammation for inflammatory bowel disease...

A study in JAMA reported that the YEARS diagnostic algorithm can serve as a frontline approach for pulmonary embolism in cancer patients, achieving performance comparable to computed tomographic...

Apnimed is positioning an IPO to fund the commercial launch of an obstructive sleep apnea therapy that is awaiting an FDA decision. The update ties financing expectations directly to an FDA...